[go: up one dir, main page]

GB0623740D0 - Treatment of disease - Google Patents

Treatment of disease

Info

Publication number
GB0623740D0
GB0623740D0 GBGB0623740.8A GB0623740A GB0623740D0 GB 0623740 D0 GB0623740 D0 GB 0623740D0 GB 0623740 A GB0623740 A GB 0623740A GB 0623740 D0 GB0623740 D0 GB 0623740D0
Authority
GB
United Kingdom
Prior art keywords
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0623740.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurocrine UK Ltd
Original Assignee
Diurnal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diurnal Ltd filed Critical Diurnal Ltd
Priority to GBGB0623740.8A priority Critical patent/GB0623740D0/en
Publication of GB0623740D0 publication Critical patent/GB0623740D0/en
Priority to PCT/GB2007/004536 priority patent/WO2008065386A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0623740.8A 2006-11-28 2006-11-28 Treatment of disease Ceased GB0623740D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0623740.8A GB0623740D0 (en) 2006-11-28 2006-11-28 Treatment of disease
PCT/GB2007/004536 WO2008065386A1 (en) 2006-11-28 2007-11-27 Treatment of disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0623740.8A GB0623740D0 (en) 2006-11-28 2006-11-28 Treatment of disease

Publications (1)

Publication Number Publication Date
GB0623740D0 true GB0623740D0 (en) 2007-01-10

Family

ID=37671451

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0623740.8A Ceased GB0623740D0 (en) 2006-11-28 2006-11-28 Treatment of disease

Country Status (2)

Country Link
GB (1) GB0623740D0 (en)
WO (1) WO2008065386A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401031D0 (en) 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
WO2010115615A1 (en) * 2009-04-07 2010-10-14 Duocort Pharma Ab Improved glucocorticoid therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10012555A1 (en) * 2000-03-15 2001-09-20 Merck Patent Gmbh Composition for rapid release of corticoid drugs after delay period, useful for drug delivery during the night, e.g. for preventing asthma, or for delivery to colon for treating inflammatory bowel disease
GB0119848D0 (en) * 2001-08-15 2001-10-10 Univ Sheffield Delayed and sustained drug release
GB0400031D0 (en) * 2004-01-03 2004-02-04 Univ Sheffield Depression treatment

Also Published As

Publication number Publication date
WO2008065386A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
IL194076A0 (en) Imidazolothiazole compounds for the treatment of disease
GB0610867D0 (en) Treatment of pain
GB0602178D0 (en) Therapeutic treatment
IL198663A0 (en) Tissue treatment methods
IL193748A0 (en) Treatment of pain
SI2056807T1 (en) Treatment of inflammatory diseases
IL197315A0 (en) Treatment of cancer
EP2160100B8 (en) Treatment of graft-versus-host disease
EP2049139A4 (en) Treatment of ras-expressing tumors
ZA200806808B (en) Treatment of stressed patients
PT2056863T (en) Treatment of ocular diseases
PL2056858T3 (en) Treatment of pulmonary disease conditions
GB0700972D0 (en) Treatment of inflammatory disease
GB0600692D0 (en) Well treatment
GB0608655D0 (en) Therapeutic Treatment
GB0720976D0 (en) Treatment of inflammatory disease
GB0610909D0 (en) Therapeutic treatment
GB0723100D0 (en) Treatment of HFnEF
GB0610868D0 (en) Treatment of pain
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
GB0623740D0 (en) Treatment of disease
GB0604460D0 (en) Treatment
GB0622136D0 (en) Treatment of gastrointestinal diseases
ZA200904660B (en) Treatment of IL-1-Beta related diseases
GB0616450D0 (en) Treatment of pain

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)